078160.KQ
MEDIPOST Co., Ltd.
KOE · Healthcare · Biotechnology · KR
KRW 8,690.00
−0.23%Year over year
Reported trailing growth
- Revenue
- +3.7%
- EBITDA
- -38.5%
- EBIT
- +29.6%
- EPS
- +75.8%
- Free cash flow
- -16.6%
- Operating cash flow
- -12.8%
Forward estimates
Based on analyst estimates
- Revenue
- -28.0%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +4.7%
- EBITDA
- -12.1%
- EBIT
- -40.0%
- Net income
- -36.6%
- EPS
- -19.6%
- Free cash flow
- -48.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026